AF
IBDX icon

Arrow Financial’s iShares iBonds Dec 2032 Term Corporate ETF IBDX Stock Holding History

Arrow Financial’s Portfolio IBDX Stock Details IBDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$15.5M Buy
614,512
+15,366
+3% +$392K 1.56% 13
2025
Q4 		$15.3M Buy
599,146
+22,170
+4% +$567K 1.52% 14
2025
Q3 		$14.8M Sell
576,976
-15,023
-3% -$381K 1.51% 14
2025
Q2 		$15M Sell
591,999
-5,192
-0.9% -$129K 1.58% 13
2025
Q1 		$14.9M Sell
597,191
-2,752
-0.5% -$68.1K 1.67% 11
2024
Q4 		$14.7M Buy
599,943
+14,943
+3% +$374K 1.4% 14
2024
Q3 		$15M Buy
585,000
+11,981
+2% +$303K 1.39% 14
2024
Q2 		$14.1M Buy
573,019
+18,130
+3% +$443K 1.37% 15
2024
Q1 		$13.8M Buy
554,889
+25,348
+5% +$628K 1.37% 15
2023
Q4 		$13.4M Buy
529,541
+68,783
+15% +$1.64M 1.39% 14
2023
Q3 		$10.8M Buy
460,758
+164,304
+55% +$3.97M 1.27% 24
2023
Q2 		$7.3M Buy
296,454
+105,489
+55% +$2.61M 0.88% 30
2023
Q1 		$4.79M Buy
+190,965
New +$4.73M 0.62% 42

Other funds holding IBDX

ACA
Aptus Capital Advisors Fairhope, Alabama $12.7B AUM 17.41% 1-Year Est. Return
CIA
Capital Investment Advisors Atlanta, Georgia $6.84B AUM 17.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
CAI
Capital Advisors Inc Tulsa, Oklahoma $6.22B AUM 22.28% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
SF
Summit Financial Parsippany, New Jersey $7.85B AUM 20.99% 1-Year Est. Return
SIC
Sigma Investment Counselors Northville, Michigan $1.89B AUM 14.55% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
KA
Klingman & Associates New York $2.09B AUM 16.49% 1-Year Est. Return

Arrow Financial's IBDX Position: Q1 2026 in Review

Arrow Financial increased its iShares iBonds Dec 2032 Term Corporate ETF (IBDX) stake by 2.6% in Q1 2026, buying an estimated $392K and bringing the position to 614,512 shares worth $15.5M. The position accounts for 1.56% of the portfolio, ranked #13.

Arrow Financial first reported a position in IBDX in Q1 2023 and has held it in 13 quarters since. 221 funds tracked by Wall St. Rank hold IBDX as of Q1 2026.

  • Arrow Financial held 614,512 shares of iShares iBonds Dec 2032 Term Corporate ETF worth $15.5M as of Q1 2026.
  • Arrow Financial bought 15,366 iShares iBonds Dec 2032 Term Corporate ETF shares in Q1 2026, an estimated $392K.
  • iShares iBonds Dec 2032 Term Corporate ETF made up 1.56% of Arrow Financial's portfolio in Q1 2026, its #13 holding.
  • Arrow Financial first reported a position in iShares iBonds Dec 2032 Term Corporate ETF in Q1 2023 and has held it in 13 quarters since.
  • 221 funds tracked by Wall St. Rank held iShares iBonds Dec 2032 Term Corporate ETF as of Q1 2026.

Based on Arrow Financial's 13F filing for Q1 2026, filed 11 May 2026.